All
Kyprolis Continues to Advance in Multiple Myeloma
October 14th 2015The agent gained a priority review designation for use in combination with dexamethasone for patients with relapsed multiple myeloma following prior treatment with at least one therapy, based on findings from the phase 3 ENDEAVOR trial.
Early Data Suggest Promise for Immunotherapies in Lymphomas
October 13th 2015Questions persist regarding mechanisms of PD-L1 overexpression in lymphoid malignancies, patient selection, biomarkers to guide therapy and predict response, and identification of agents to use in combination with PD-1/PD-L1 inhibitors.
Keytruda Approved for Lung Cancer
October 3rd 2015The PD-1 inhibitor was approved along with a companion diagnostic, the PD-L1 IHC 22C3 pharmDx test, and is indicated for patients who progressed on or after platinum-containing chemotherapy or EGFR- or ALK-targeted agents in patients harboring those mutations.
Reflections From a Breast Cancer Survivor on 'Pinktober'
October 3rd 2015Every October, pink ribbons appear to signal the start of Breast Cancer Awareness Month. Pink has become the color of breast cancer, but some survivors don't like the color pink and they have a good reason for feeling the way they do.
When Your Dog Dies: Balancing Cancer and Depression
September 30th 2015Cancer is an emotional challenge all by itself. Curiously enough, a cancer diagnosis gave me a new lease on my emotional life. But sometimes a person with the best of intentions will falter. Knowing when to seek help can save a life.